Effective screening for major aneuploidies can be provided in the first trimester of pregnancy. Screening by a combination of fetal nuchal translucency and maternal serum free-β-human chorionic gonadotrophin and pregnancy-associated plasma protein-A can identify about 90% of fetuses with trisomy 21 and other major aneuploidies for a false-positive rate of 5%. Improvement in the performance…
Prenatal Diagnosis Template
Write in a clean editor, then format for Prenatal Diagnosis in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Prenatal Diagnosis format
Prenatal Diagnosis is a peer-reviewed journal published by Wiley, covering Prenatal Screening and Diagnostics, Fetal and Pediatric Neurological Disorders, Genomic variations and chromosomal abnormalities.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Prenatal Diagnosis 12 (3): 45–58.
Formats any DOI in Prenatal Diagnosis style. No sign-up. |
| Publishes research in | Prenatal Screening and Diagnostics Fetal and Pediatric Neurological Disorders Genomic variations and chromosomal abnormalities Pregnancy and preeclampsia studies Congenital Anomalies and Fetal Surgery |
| ISSN | 0197-3851 |
| Citation impact (2-yr) | 1.84 |
| h-index | 143 |
| i10-index | 5,574 |
| Total citations | 231,798 |
| Article processing charge | $4,640 |
| Top institutions publishing here | University College London |
| Journal website | obgyn.onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Prenatal Diagnosis per year
Citation impact of Prenatal Diagnosis by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Prenatal Diagnosis
OBJECTIVE: To examine the performance of the 11-13 weeks scan in detecting non-chromosomal abnormalities. METHODS: Prospective first-trimester screening study for aneuploidies, including basic examination of the fetal anatomy, in 45 191 pregnancies. Findings were compared to those at 20-23 weeks and postnatal examination. RESULTS: Aneuploidies (n = 332) were excluded from the analysis. Fetal abnormalities…
The alpha subunit of human chorionic gonadotropin (alpha-hCG), human chorionic gonadotropin (hCG) and alpha fetoprotein (AFP) were measured in the serum of 25 women with chromosomally abnormal fetuses between 18 and 25 weeks of gestation and in 74 normal pregnancies. AFP levels less than 0.5 multiples of the median (MoM) or greater than 2.5 MoM…
OBJECTIVE: To develop models for prediction of pre-eclampsia (PE) based on maternal factors and biophysical and biochemical markers at 11-13 weeks' gestation. METHODS: Screening study of singleton pregnancies at 11-13 weeks including 752 (2.2%) that subsequently developed PE and 32,850 that were unaffected by PE. Models were developed for the prediction of early PE, requiring…
OBJECTIVE: To determine the effects of gestational age and maternal weight on percent fetal cell-free DNA (cfDNA) in maternal plasma and the change in fetal cfDNA amounts within the same patient over time. METHODS: The cfDNA was extracted from maternal plasma from 22 384 singleton pregnancies of at least 10 weeks gestation undergoing the Harmony(TM)…